The Board

The board

Gunnar Olsson, Chairman, MD, Ph.D. Dr. Olsson brings more than 30 years’ experience in drug development, including 25 years at AstraZeneca. While at AstraZeneca Dr. Olsson held a number of senior roles in Global R&D including Senior VP and leader of the CV & GI Therapy Area. He certified in Cardiology and Internal Medicine in hospitals associated to Karolinska Institutet, where he was adjunct professor for 12 years. In recent years Dr Olsson has worked with innovative biotech companies in the Scandinavian region as board member or advisor. He is currently Chairman of the Board of IRLAB AB and Athera Biotechnologies AB and is a member of the Board of Gesynta AB. 

Jan M Lundberg, Ph.D. Served as the President of Lilly Research Laboratories and Executive Vice President of Science and Technology at Eli Lilly and Company (Head R&D) from 2010-2018. Dr. Lundberg served as an Executive Vice President and Head of Discovery Research at AstraZeneca PLC 2000-2009

Li Ming Gan, Head of Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D at Astra Zeneca. Prof./ Chief Physician, Department of Molecular and Clinical Medicine at the University of Gothenburg, Sahlgrenska.

Thomas Edlund, Founder, Prof. Professor Edlund has conducted more than 25 years of research at the international forefront, with results published in leading international journals on development pancreatic β-cells and the vertebrate central nervous system. He is member of the Royal Swedish Academy of Sciences and has received numerous scientific awards and prizes, and a Co-founder of Betagenon AB.

Svein Mathisen, More than 30 years of experience from management, business development and finance issues in the Life Science industry but also in the global chemical industry. He worked as CEO for twelve years at the listed pharmaceutical company, BioInvent International. Previously, he worked in leading positions within Norsk Hydro ASA. a in Life Science.

Martin Gunhaga, Head of Investments at FortKnox AB

Andreas Nordberg, Partner and Attorney at Law, Stockholm-Umeå